YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway

JOURNAL ARTICLE published December 2015 in Journal of Hematology & Oncology

Authors: Bill H Chang | Kara Johnson | Dorian LaTocha | Joelle S J Rowley | Jade Bryant | Russell Burke | Rebecca L Smith | Marc Loriaux | Markus Müschen | Charles Mullighan | Brian J Druker | Jeffrey W Tyner

Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients

JOURNAL ARTICLE published December 2012 in Journal of Hematology & Oncology

Authors: Yan-Fang Wang | Yan-Li Yang | Zi-Fen Gao | Chun-Ju Zhou | Xylina Gregg | Yun-Fei Shi | Jing Wang | Xiao-Feng Yang | Xiao-Yan Ke

8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia

JOURNAL ARTICLE published December 2014 in Journal of Hematology & Oncology

Authors: Yoshiaki Chinen | Natsumi Sakamoto | Hisao Nagoshi | Tomohiko Taki | Saori Maegawa | Shotaro Tatekawa | Taku Tsukamoto | Shinsuke Mizutani | Yuji Shimura | Mio Yamamoto-Sugitani | Tsutomu Kobayashi | Yosuke Matsumoto | Shigeo Horiike | Junya Kuroda | Masafumi Taniwaki

Complications of Evans' syndrome in an infant with hereditary spherocytosis: a case report

JOURNAL ARTICLE published December 2009 in Journal of Hematology & Oncology

Authors: Hideki Yoshida | Hiroyuki Ishida | Takao Yoshihara | Takashi Oyamada | Masataka Kuwana | Toshihiko Imamura | Akira Morimoto

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia

JOURNAL ARTICLE published December 2014 in Journal of Hematology & Oncology

Authors: Shilpan Shah | Sanam Loghavi | Guillermo Garcia-Manero | Joseph D Khoury

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

JOURNAL ARTICLE published December 2010 in Journal of Hematology & Oncology

Authors: Matthias Schwenkglenks | Ruth Pettengell | Thomas D Szucs | Eva Culakova | Gary H Lyman

DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas

JOURNAL ARTICLE published December 2020 in Journal of Hematology & Oncology

Research funded by National Institutes of Health (R01CA211963,R01CA219836,R01CA242003,R21CA223371,R35CA239158,R01CA241191) | Deutsche Forschungsgemeinschaft (KO 4627/2-1) | Leukemia and Lymphoma Society (#7011-16)

Authors: Yonghan He | Raphael Koch | Vivekananda Budamagunta | Peiyi Zhang | Xuan Zhang | Sajid Khan | Dinesh Thummuri | Yuma T. Ortiz | Xin Zhang | Dongwen Lv | Janet S. Wiegand | Wen Li | Adam C. Palmer | Guangrong Zheng | David M. Weinstock | Daohong Zhou

Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma

JOURNAL ARTICLE published 21 October 2022 in Journal of Hematology & Oncology

Research funded by Institut National Du Cancer (CLIP2)

Authors: Maud Toulmonde | Sophie Cousin | Michèle Kind | Jean-Philippe Guegan | Alban Bessede | Francois Le Loarer | Raul Perret | Coralie Cantarel | Carine Bellera | Antoine Italiano

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

JOURNAL ARTICLE published December 2018 in Journal of Hematology & Oncology

Authors: Reham Abdel-Wahab | Gauri R. Varadhachary | Priya R. Bhosale | Xuemei Wang | David R. Fogelman | Rachna T. Shroff | Michael J. Overman | Robert A. Wolff | Milind Javle

Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy

JOURNAL ARTICLE published December 2016 in Journal of Hematology & Oncology

Research funded by National Natural Science Foundation of China (81372260)

Authors: Fei-fei Gu | Yong Zhang | Yang-yang Liu | Xiao-hua Hong | Jin-yan Liang | Fan Tong | Jing-song Yang | Li Liu

Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models

JOURNAL ARTICLE published December 2016 in Journal of Hematology & Oncology

Authors: Christian Lehmann | Thomas Friess | Fabian Birzele | Anna Kiialainen | Markus Dangl

SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status

JOURNAL ARTICLE published December 2009 in Journal of Hematology & Oncology

Authors: Ayad M Al-Katib | Yuan Sun | Anton Scott Goustin | Asfar Sohail Azmi | Ben Chen | Amro Aboukameel | Ramzi M Mohammad

Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663

JOURNAL ARTICLE published December 2011 in Journal of Hematology & Oncology

Authors: Pan Jian | Zhao Wen Li | Tao Yan Fang | Wang Jian | Zhou Zhuan | Liao Xin Mei | Wu Shui Yan | Ni Jian

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders

JOURNAL ARTICLE published December 2022 in Journal of Hematology & Oncology

Authors: José Luis Piñana | Lucia López-Corral | Rodrigo Martino | Lourdes Vazquez | Ariadna Pérez | Gabriel Martin-Martin | Beatriz Gago | Gabriela Sanz-Linares | Andrés Sanchez-Salinas | Lucia Villalon | Venancio Conesa-Garcia | María T. Olave | Magdalena Corona | Sara Marcos-Corrales | Mar Tormo | José Ángel Hernández-Rivas | Juan Montoro | Alicia Rodriguez-Fernandez | Irene Risco-Gálvez | Pablo Rodríguez-Belenguer | Juan Carlos Hernandez-Boluda | Irene García-Cadenas | Montserrat Ruiz-García | Juan Luis Muñoz-Bellido | Carlos Solano | Ángel Cedillo | Anna Sureda | David Navarro | the Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)

Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia

JOURNAL ARTICLE published December 2020 in Journal of Hematology & Oncology

Authors: Guido Lancman | John Mascarenhas | Michal Bar-Natan

Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA

JOURNAL ARTICLE published December 2018 in Journal of Hematology & Oncology

Authors: Simon Heine | Markus Kleih | Neus Giménez | Kathrin Böpple | German Ott | Dolors Colomer | Walter E. Aulitzky | Heiko van der Kuip | Elisabeth Silkenstedt

Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies

JOURNAL ARTICLE published December 2017 in Journal of Hematology & Oncology

Authors: Jun Liu | Jiang F. Zhong | Xi Zhang | Cheng Zhang

Journal of Hematology & Oncology reviewer acknowledgement 2015

JOURNAL ARTICLE published December 2016 in Journal of Hematology & Oncology

Authors: Delong Liu

Molecular alterations in the TCR signaling pathway in patients with aplastic anemia

JOURNAL ARTICLE published December 2016 in Journal of Hematology & Oncology

Research funded by National Natural Science Foundation of China (No.81370605 and No.81460026) | China Post-doctoral Science Foundation funded project (No.20070410840) | Natural Science Foundation of Guangdong Province (No.S2012010008794 and No.S20130200-12863) | Technology Program of Guangdong Province (No.2014A020212209) | Foundation for High-level Talents in Higher Education of Guangdong, China (No.[2013]246-54) | Science and Information Technology of Guangzhou funded basic research for application project (No.2011J4100028) | Fundamental Research Funds for the Central Universities (No.21612425)

Authors: Bo Li | Lixing Guo | Yuping Zhang | Yankai Xiao | Mingjuan Wu | Lingling Zhou | Shaohua Chen | Lijian Yang | Xiang Lu | Yangqiu Li

Updates in non-small cell lung cancer - insights from the 2009 45th annual meeting of the American Society of Clinical Oncology

JOURNAL ARTICLE published December 2010 in Journal of Hematology & Oncology

Authors: Hamid R Mirshahidi | Chung T Hsueh